Sponsor

Royal Devon and Exeter NHS Foundation Trust

Clinical research sponsor

Published trials38
Recruiting shown5
Roles2
SourceClinicalTrials.gov

Clinical trials

38 shown
Benefits of Retained Insulin for Good HealthNCT07828626 · lead sponsor · 2025-10-31
RECRUITING
Experience of Biologic Treatments for Severe Asthma: a SurveyNCT06903780 · lead sponsor · 2025-01-01
RECRUITING
Assessing Remote Confirmation of Type 1 DiabetesNCT06821360 · lead sponsor · 2024-12-03
ENROLLING_BY_INVITATION
GUM Remote Testing v4.0NCT06244966 · lead sponsor · 2024-05-01
UNKNOWN
Laser Speckle Imaging During Breast ReconstructionNCT06523452 · lead sponsor · 2024-04-25
UNKNOWN
Day-case Endourology; Patient ExperienceNCT06152679 · lead sponsor · 2023-12-01
UNKNOWN
Evaluating ImmuNe Changes in the Evolution of Pre Type 1 Diabetes With Adult ONsetNCT06006468 · lead sponsor · 2023-02-01
COMPLETED
Adapting Body Reprogramming for Severe Asthma: a Feasibility StudyNCT04980755 · lead sponsor · 2021-07-28
COMPLETED
NEWBIE Validate: Feasibility of a New Test to Measure Glucose in Newborn Blood Spots (NBS)NCT04831723 · lead sponsor · 2021-07-09
COMPLETED
Defining the Decline in Endogenous Insulin Secretion in Type 1 Diabetes Diagnosed After 30 Years of Age.NCT04682457 · lead sponsor · 2019-11-01
COMPLETED
The Genetics of Adipose Tissue Function and Its Link to Type 2 Diabetes and Heart DiseaseNCT04040595 · lead sponsor · 2019-03-07
COMPLETED
Comparison of SITA-Standard Compared to SITA-Fast Visual Fields.NCT03192085 · lead sponsor · 2017-07-01
UNKNOWN
TriMaster: Study of a DPP4 Inhibitor, SGLT2 Inhibitor and Thiazolidinedione as Third Line Therapy in Patients With Type 2 Diabetes.NCT02653209 · lead sponsor · 2016-11-01
COMPLETED
StartRight: Getting the Right Classification and Treatment From Diagnosis in Adults With DiabetesNCT03737799 · lead sponsor · 2016-08-01
UNKNOWN
Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) SyndromeNCT05751525 · lead sponsor · 2016-07-01
UNKNOWN
Effect of Food Composition on Postprandial Insulin Secretion in Neonatal DiabetesNCT02921906 · lead sponsor · 2016-06-01
COMPLETED
StartRIGHT: A Pilot Research Study About Diabetes Diagnosis & TreatmentNCT02287506 · lead sponsor · 2015-08-28
TERMINATED
for Adipose Tissue DIabetes VAriants (fATDIVA)NCT02505321 · lead sponsor · 2015-05-29
COMPLETED
Defining the Molecular and Physiological Mechanisms of Pancreatic Islet Cell Dysfunction Which Lead to Type 2 DiabetesNCT02505308 · lead sponsor · 2015-03-04
COMPLETED
Type 1 Diabetes, Immunology, Genetics & Endogenous Insulin ProductionNCT03490773 · lead sponsor · 2014-11-01
COMPLETED
Glucose Response, Excursions And Treatment (GREAT) StudyNCT02506296 · lead sponsor · 2014-10-01
COMPLETED
RetroMASTER - Retrospective Cohort MRC ABPI STratification and Extreme Response Mechanism in DiabetesNCT02109978 · lead sponsor · 2013-04-01
COMPLETED
MASTERMIND - Understanding Individual Variation in Treatment Response in Type 2 DiabetesNCT01847144 · lead sponsor · 2013-04-01
COMPLETED
PROMASTER - PROspective Cohort MRC ABPI STratification and Extreme Response Mechanism in DiabetesNCT02105792 · lead sponsor · 2013-03-01
COMPLETED
Predicting Response to Incretin Based Agents in Type 2 DiabetesNCT01503112 · lead sponsor · 2011-05-01
COMPLETED
GLP-1 and Microvascular Function in Type 2 DiabetesNCT01740921 · lead sponsor · 2011-01-01
COMPLETED
Obstructive Sleep Apnoea and Adipose Tissue DysfunctionNCT02518633 · lead sponsor · 2010-03-01
COMPLETED
Sulfonylurea Response in Patients With Diabetes Due to Kir6.2 MutationsNCT00334711 · lead sponsor · 2004-01-01
COMPLETED
Understanding Beta Cell Disorders Through the Study of Rare Genotypes (ENDURE)NCT06478121 · collaborator · 2025-11-11
RECRUITING
Feasibility Study to Investigate Rectal Mucus in Aero-Digestive Tract Cancer.NCT05102110 · collaborator · 2021-12-01
RECRUITING
EXtremely Early-onset Type 1 Diabetes EXtremely Early-onset Type 1 Diabetes (A Musketeers' Memorandum Study)NCT03369821 · collaborator · 2017-09-19
RECRUITING
Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 DiabetesNCT05616273 · collaborator · 2023-05-03
COMPLETED
Co-morbidity and Refractory Asthma - UK Severe Asthma RegistryNCT04553276 · collaborator · 2020-08-26
ENROLLING_BY_INVITATION
Long-Term Sulfonylurea Response in ABCC8 Neonatal Diabetes (SuResponsSUR)NCT02624830 · collaborator · 2019-02-15
UNKNOWN
Long-Term Sulfonylurea Response in KCNJ11 Neonatal DiabetesNCT02624817 · collaborator · 2015-12-01
COMPLETED
Effects of Nitrate on Liver Perfusion and Sugar ControlNCT02195856 · collaborator · 2014-07-01
COMPLETED
DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R AgonistsNCT01575301 · collaborator · 2011-03-01
COMPLETED
WT1 Immunity Via DNA Fusion Gene Vaccination in Haematological Malignancies by Intramuscular Injection Followed by Intramuscular ElectroporationNCT01334060 · collaborator · 2011-02-01
COMPLETED

Sponsor roles

lead sponsor28
collaborator10

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.